Therapeutic Catalyst
Therapeutic Catalyst funds exploratory drug discovery projects to validate and de-risk targets with the aim of developing novel single-agent anti-tumour therapies. Projects are collaborative between academic teams and Cancer Research Horizons’ Therapeutic Innovation drug discovery labs, with an assigned scientist supporting proposal development and regular advisory meetings while the grant-hol…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
National Institutes of Health
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
National Institutes of Health
-
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
-
RFA: EDS Accelerator Award
American Cancer Society
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers